Gesund.ai Exits Stealth with $2M in Funding
Gesund’s superhighway of clinical-grade AI clears the way to safer, more effective tools to help improve medical outcomes for patients.
Florida / New York
Ph: 561.316.3330
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
Gesund’s superhighway of clinical-grade AI clears the way to safer, more effective tools to help improve medical outcomes for patients.
The funds will be used to finalize product development and initiate a first-in-human clinical study for the company’s high-flow, low-profile percutaneous ventricular assist device (pVAD).
Lazurite Holdings had announced its collaboration with UH Ventures on a human factors study of the ArthroFree™ system in August.
Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved
Hours:
M – F 8 am – 5 pm
Florida / New York
Phone: 561.316.3330